Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Theratechnologies (TH.TO)
Theratechnologies (TH.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 90,121
  • Shares Outstanding, K 45,980
  • Annual Sales, $ 81,764 K
  • Annual Income, $ -23,957 K
  • 60-Month Beta 1.35
  • Price/Sales 0.48
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade TH.TO with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.91
  • Most Recent Earnings $-0.03 on N/A
  • Latest Earnings Date 04/10/24
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

    TSX Biotechnology

    TSX Bottom 100 Stocks

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 02/29/24
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.60
  • Growth Rate Est. (year over year) +166,600.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.96 +2.55%
on 02/28/24
2.40 -16.25%
on 02/14/24
-0.26 (-11.45%)
since 01/29/24
3-Month
1.88 +6.91%
on 01/25/24
3.43 -41.40%
on 01/08/24
-0.24 (-10.67%)
since 11/29/23
52-Week
1.22 +64.75%
on 09/01/23
5.84 -65.58%
on 05/04/23
-3.15 (-61.05%)
since 02/28/23

Most Recent Stories

More News
Theratechnologies: Fiscal Q4 Earnings Snapshot

Theratechnologies: Fiscal Q4 Earnings Snapshot

TH.TO : 2.01 (+2.55%)
Stocks in play: Theratechnologies Inc.

Announced the publication of a peer-reviewed article in Frontiers in Immunology that enhances understanding ...

TH.TO : 2.01 (+2.55%)
Theratechnologies Announces Renewal of Shelf Prospectus and Filing of Registration Statement

/CNW/ - Theratechnologies Inc. ("Theratechnologies" or the "Company") (Nasdaq: THTX) (TSX: TH), a biopharmaceutical company focused on the development and...

THTX : 1.4500 (+0.69%)
TH.TO : 2.01 (+2.55%)
Stocks in play: Theratechnologies Inc.

Today announced receipt of the 2023 Industrial Research Sectoral Group (RSRI) Innovation Award from ...

TH.TO : 2.01 (+2.55%)
Stocks in play: Theratechnologies Inc.

Today announced further changes to its operations that will see a tapering of R&D activities, which ...

TH.TO : 2.01 (+2.55%)
Stocks in play: Theratechnologies Inc.

Has finalized all documentation giving effect to the amendments to certain of the terms and conditions ...

TH.TO : 2.01 (+2.55%)
Stocks in play: Theratechnologies Inc.

Today announced results from a study evaluating an intramuscular (IM) method of administration for Trogarzo® ...

TH.TO : 2.01 (+2.55%)
Stocks in play: Theratechnologies Inc.

Today announced that the U.S. Food and Drug Administration (FDA) has assigned a Prescription Drug User ...

TH.TO : 2.01 (+2.55%)
Theratechnologies: Fiscal Q3 Earnings Snapshot

Theratechnologies: Fiscal Q3 Earnings Snapshot

TH.TO : 2.01 (+2.55%)
Stocks in play: Theratechnologies Inc.

Has filed a supplemental Biologics License Application (sBLA) for the F8 formulation of tesamorelin ...

TH.TO : 2.01 (+2.55%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

3rd Resistance Point 2.09
2nd Resistance Point 2.06
1st Resistance Point 2.04
Last Price 2.01
1st Support Level 1.99
2nd Support Level 1.96
3rd Support Level 1.94

See More

52-Week High 5.84
Fibonacci 61.8% 4.08
Fibonacci 50% 3.53
Fibonacci 38.2% 2.98
Last Price 2.01
52-Week Low 1.22

See More

Business Summary

Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization...

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar